TALGO: 9M’20 RESULTS (ANÁLISIS BANCO SABADELL)
3Q'20 vs. 3Q'19 Results
Sales: € 122.8 M (+14.0% vs. +5.1% BS(e) and +7.5% consensus);
EBITDA: € 7.9 M (-64.4% vs. -71.2% BS(e) and -65.8% consensus);
EBIT: € 7.5 M (-55.4% vs. € -1.0 M BS(e) and -89.9% consensus);
Net Profit: € -0.6 M (€ 11.4 M in 9M'19 vs. € -3.1 M BS(e) and € 0.2 M consensus).
9M'20 vs. 9M'19 Results
Sales: € 339.4 M (+23.2% vs. +19.7% BS(e) and +20.7% consensus);
EBITDA: € 22.6 M (-56.7% vs. -59.6% BS(e) and -57.3% consensus);
EBIT: € 9.3 M (-77.8% vs. -98.1% BS(e) and -91.6% consensus);
Net Profit: € -6.3 M (€ 26.2 M in 9M'19 vs. € -8.8 M BS(e) and € -5.5 M consensus).
At yesterday’s closing bell, the company released its 3Q’20 results, which continued to show an impact from Covid-19 (in Maintenance activity). Sales came in above expectations (+6% vs. BS(e) and +8% vs. consensus), whereas EBITDA was very much in line with the consensus’ estimate and slightly above ours (€ 7.9 M vs. € 6.4 M BS(e) and € 7.6 M consensus). We recall that the company does not provide balance sheet data in its 9M results.
Thus, sales increased by +14% vs. 3Q’19 (+23% as of 9M’20) to € 123 M (vs. € 104 M in 2Q’20 and € 155 M BS(e) pre Covid-19), impacted by Covid-19 mainly in Maintenance activity (no breakdown of data provided). This impact is amplified on the EBITDA level, as the fall in activity causes a lower absorption of fixed costs (and possible cost overruns), bringing the quarter’s adjusted EBITDA to only € 7.9 M (vs. € 6.4 M BS(e) and € 7.6 M consensus; -64% vs. 3Q’19), with a margin of 6.4% (vs. 6.4% BS(e) and 6.6% consensus). As of 9M’20, adjusted EBITDA totalled € 23 M (-57% vs. 9M’19; 6.7% margin). The quarter’s adjusted Net Profit came in at -0.6 M (vs. €-3.5 M BS(e) and € 0.8 M consensus).
Following this set of results, and bearing in mind how the pandemic is playing out globally, we will have to cut our EBITDA estimate’20 by at least -35% (to € 34 M vs. € 47 M consensus), assuming activity levels in 4Q in line with 3Q. Thus, even assuming for 2021 and 2022 the same Maintenance activity as in 2020 (-60% vs. before Covid-19), which in our view is an overly pessimistic scenario, the negative impact on our valuation would not exceed -11%, which would still yield upside higher than +45%.
Thus, although this set of results might lead to estimate downgrades, bearing in mind that this was already expected and that the results came in slightly above expectations, we would expect a neutral share price reaction, especially after the stock has underperformed the IBEX by -20% since February’s pre Covid-19 highs. Conference call at 12:00 (CET). BUY. T.P. € 5.88/sh. (+66.10% upside).